Sandoz Group AG (SDZXF)

36.07 0.00 (0.00%) At close: 10:51AM EDT

Sandoz Group AG

Forum 1
Novartis Campus
Basel 4056
Switzerland
41 61 324 11 11
https://www.sandoz.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 22,633

Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Corporate governance

Sandoz Group AG’s ISS governance QualityScore as of 1 June 2024 is 3. The pillar scores are Audit: 6; Board: 4; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.